Strategic Partnerships Leverage existing high-profile clients like L’Oréal, FMC, and British American Tobacco to expand consulting and in vitro toxicology services, highlighting joint development opportunities, co-authored studies, and broader product safety testing collaborations.

Small but Specialized Position IONTOX as a boutique toxinology partner with deep in vitro and mechanistic toxicology capabilities, targeting mid-market pharma and consumer goods firms seeking specialized outsourcing for safety evaluations without the overhead of larger CROs.

Lung-Liver Model Advantage Capitalize on the lung-liver-lung model collaboration with BAT as a proof point for advanced organ-on-a-chip style studies and simulated blood systems, offering differentiating studies for tobacco, nicotine products, and inhalation risk assessments.

Growth Through Web & Tools Highlight the tech-enabled service delivery and client engagement stack (LiveChat, ActiveCampaign, e-commerce capabilities) to streamline inquiries, quotes, and repeat business, appealing to clients seeking responsive, transparent toxicology partnerships.

Commercial Readiness Promote readiness for scale by stressing small Revenue profile (<$1M) as an opportunity for customizable, high-touch service levels with clear SLAs, potentially onboarding additional mid-size chemical and cosmetics clients needing robust safety testing and regulatory support.